Here at Value Stocks (membership count: 830 and growing), members do not chase stocks on the rise. The following biotech and healthcare stocks are therefore on the watch list, for now. If they dip, we'll consider them.Luminex $LMNX: Luminex rose on May 8 after first quarter results impressed investors. Revenue grew 6.3% to $82.7M. Net income rose 45.7% to $13.4 million. LMNX forecast 2018 revenue in the range of $310-$316M. The key number: 60 sample-to-answer molecular systems under contract represented growth of 76.5%. Remember Exact Sciences? $EXAS diagnostic order growth drove shares higher. EXAS is a past monthly biotech pick. $LMNX, Luminex Corporation / H1 Steris - $STE is a medical instruments provider. In Q4, EPS of $1.24 on revenue of $715.97M both beat expectations. STE has a modest outlook for 2019. It expects revenue growing at 4 – 5 percent. It will get $30 million from currency Y/Y benefits. This offsets the negative impact of divestitures. $STE, STERIS plc (Ireland) / H1 Past biotech picks that played out: $SRPT - Sarepta.Exact Sciences.Kerx $KERXPick not playinng out: Synergy Pharma $SGYP.